Civic IQ
CONTRACTONGOING
Get alerts

Gainwell Updates Texas SGLT2 Medication Review

Texas Health and Human Services | State of Texas logoTexas Health and Human Services | State of Texas
Document date
Jul 16, 2026

The 30-second brief

What it covers

Gainwell Technologies provided Texas Health and Human Services Commission with an updated therapeutic class review of SGLT2 inhibitor medications. The report supports pharmacy and clinical decision-making, but does not state a contract amount or expiration date.

Who holds it

Gainwell Technologies LLC holds this professional services contract with Texas Health and Human Services | State of Texas. Its other public contracts on record include work for TX-State-Texas Health and Human Services and Comptroller of Maryland|Office of the Comptroller.

See every contract and contact at Texas Health and Human Services | State of Texas.

See every contract

Free account · 30-second setup · No credit card

Contract details

Contract type
Professional Services
Document date
July 16, 2026
Vendor
Gainwell Technologies LLC
Agency
Texas Health and Human Services | State of Texas
Source document
Texas Health and Human Services Commission Report Therapeutic Class Review: Hypoglycemics, SGLT2 Inhibitors 2026-07-16 (Report)

Gainwell Technologies LLC's other public contracts

TX-State-Texas Health and Human Services, TexasGainwell Updates Therapeutic Drug Review for TX HHSC · Oct 1, 2026UndisclosedTX-State-Texas Health and Human Services, TexasGainwell Provides Anticonvulsant Review for TX HHSC · Jul 16, 2026UndisclosedComptroller of Maryland|Office of the Comptroller, MarylandGainwell ImmuNet System Support Extended to 2028 · Jun 18, 2026$2.4MTennessee Fiscal Review Committee | State of Tennessee, TennesseeProposed Gainwell Technologies Contract Scheduled · May 13, 2026UndisclosedFresno County, CaliforniaCounty Purchases Extended Warranty for CalSAWS Kiosk Printers · May 12, 2026All Gainwell Technologies LLC contractsVendor profile

More Texas Health and Human Services | State of Texas contracts

Gainwell Technologies LLCGainwell Updates Therapeutic Drug Review for TX HHSC · Oct 1, 2026UndisclosedAcentra HealthAcentra Health Assesses Pediatric Antibiotic Intervention · Sep 1, 2026UndisclosedAcentra HealthAcentra Health Conducts Medicaid Drug Review Intervention · Sep 1, 2026UndisclosedAcentra HealthAcentra Health Provides Medicaid Drug Review Services · Sep 1, 2026UndisclosedGainwell TechnologiesGainwell Updates Insulin Therapeutic Class Review · Jul 16, 2026UndisclosedAll Texas Health and Human Services | State of Texas activityAgency profile

Questions about this contract

Who was awarded the professional services contract by Texas Health and Human Services | State of Texas?

Gainwell Technologies LLC was awarded this professional services contract by Texas Health and Human Services | State of Texas, as recorded on July 16, 2026.

What type of contract is this?

This is a Professional Services contract, documented as a report record.

Where was this contract approved?

This contract appears in Texas Health and Human Services Commission Report Therapeutic Class Review: Hypoglycemics, SGLT2 Inhibitors 2026-07-16 (Report), dated July 16, 2026 from Texas Health and Human Services | State of Texas. Civic IQ extracts contract records directly from agency meeting documents and solicitations.

What other contracts does Gainwell Technologies LLC hold?

Gainwell Technologies LLC may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.

Show 1 more question

What is Texas Health and Human Services | State of Texas currently buying?

Explore Texas Health and Human Services | State of Texas's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.

Work in government? Get Civic IQ free →
More Texas Health and Human Services | State of Texas contracts →Browse all agencies in Texas →